Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04167137
Title Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Synlogic
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado School of Medicine Aurora Colorado 80045 United States Details
Hackensack University John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Ohio State University College of Medicine Columbus Ohio 43210 United States Details
University of Pittsburgh Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field